Eastwood Bio Medical Canada Stock Price Prediction
| EBM Stock | CAD 0.75 0.05 6.25% |
Oversold Vs Overbought
59
Oversold | Overbought |
Quarterly Revenue Growth 0.007 |
Using Eastwood Bio-Medical hype-based prediction, you can estimate the value of Eastwood Bio Medical Canada from the perspective of Eastwood Bio-Medical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Eastwood Bio-Medical to buy its stock at a price that has no basis in reality. In that case, they are not buying Eastwood because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Eastwood Bio-Medical after-hype prediction price | CAD 0.81 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Eastwood |
Eastwood Bio-Medical After-Hype Price Prediction Density Analysis
As far as predicting the price of Eastwood Bio-Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Eastwood Bio-Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Eastwood Bio-Medical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Eastwood Bio-Medical Estimiated After-Hype Price Volatility
In the context of predicting Eastwood Bio-Medical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Eastwood Bio-Medical's historical news coverage. Eastwood Bio-Medical's after-hype downside and upside margins for the prediction period are 0.04 and 22.69, respectively. We have considered Eastwood Bio-Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Eastwood Bio-Medical is out of control at this time. Analysis and calculation of next after-hype price of Eastwood Bio Medical is based on 3 months time horizon.
Eastwood Bio-Medical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Eastwood Bio-Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eastwood Bio-Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Eastwood Bio-Medical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.05 | 21.88 | 0.06 | 0.02 | 1 Events / Month | 1 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.75 | 0.81 | 8.00 |
|
Eastwood Bio-Medical Hype Timeline
Eastwood Bio Medical is currently traded for 0.75on TSX Venture Exchange of Canada. The entity has historical hype elasticity of 0.06, and average elasticity to hype of competition of -0.02. Eastwood is estimated to increase in value after the next headline, with the price projected to jump to 0.81 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is anticipated to be 8.0%, whereas the daily expected return is currently at 2.05%. The volatility of related hype on Eastwood Bio-Medical is about 194488.89%, with the expected price after the next announcement by competition of 0.73. The company has Profit Margin (PM) of (0.74) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.51) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.51. Assuming the 90 days horizon the next estimated press release will be very soon. Check out Eastwood Bio-Medical Basic Forecasting Models to cross-verify your projections.Eastwood Bio-Medical Related Hype Analysis
Having access to credible news sources related to Eastwood Bio-Medical's direct competition is more important than ever and may enhance your ability to predict Eastwood Bio-Medical's future price movements. Getting to know how Eastwood Bio-Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Eastwood Bio-Medical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| COV | Covalon Technologies | 0.00 | 2 per month | 2.32 | 0.04 | 6.30 | (3.30) | 15.59 | |
| SBM | Sirona Biochem Corp | (0.01) | 1 per month | 7.53 | 0.04 | 20.00 | (15.38) | 67.78 | |
| ARCH | Arch Biopartners | (0.04) | 1 per month | 2.14 | 0.14 | 5.33 | (3.43) | 14.50 | |
| BTI | biOasis Technologies | 0.00 | 1 per month | 0.00 | 0.28 | 24,900 | (99.60) | 25,600 |
Eastwood Bio-Medical Additional Predictive Modules
Most predictive techniques to examine Eastwood price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eastwood using various technical indicators. When you analyze Eastwood charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Eastwood Bio-Medical Predictive Indicators
The successful prediction of Eastwood Bio-Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Eastwood Bio Medical Canada, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Eastwood Bio-Medical based on analysis of Eastwood Bio-Medical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Eastwood Bio-Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Eastwood Bio-Medical's related companies. | 2021 | 2022 | 2024 (projected) | Graham Number | 0.0106 | 0.0396 | 0.062 | Receivables Turnover | 65.37 | 10.48 | 11.45 |
Story Coverage note for Eastwood Bio-Medical
The number of cover stories for Eastwood Bio-Medical depends on current market conditions and Eastwood Bio-Medical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Eastwood Bio-Medical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Eastwood Bio-Medical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Eastwood Bio-Medical Short Properties
Eastwood Bio-Medical's future price predictability will typically decrease when Eastwood Bio-Medical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Eastwood Bio Medical Canada often depends not only on the future outlook of the potential Eastwood Bio-Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eastwood Bio-Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 68.9 M | |
| Cash And Short Term Investments | 18.4 K |
Additional Tools for Eastwood Stock Analysis
When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.